Home | Publications | Treatments | Eye care place holder
place holder place holder

Eye care


Eye Care in Japan


Publication Date   September 2007
Publisher   Euromonitor International
Product Type   Report
Pages   48
ISBN Number   not applicable
Product Code   EUR804
Ask a question about this product?

Price £450.00

approximately: $795 | €571

Summary


Euromonitor International's Eye Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: standard eye care and allergy eye care

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the eye care industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


  • Otc Healthcare In Japan
  • Executive Summary
    • Ongoing Growth Due To Demographic and Lifestyle Change
    • Self-medication Brings Both Opportunity and Threat
    • Changes in Tax and Sales Network1
    • Shift Towards Nuclear Family Creates Innovative Packaging
    • Acquisiton Is Key To Future Growth
    • Vitamins and Dietary Supplements To Dominate Projected Sales
  • Key Trends and Developments2
    • Demographic Change Creates Demand for Anti-ageing Products
    • Legislation Eases Regulations on OTC Sales
    • Self-medication To Prevent Illness Needs Marketing
    • Increased Merger and Acquisition Activity in Manufacturers and Retailers
    • Increasing Number of Nuclear Families and Single-person Households Exerts A Growing Influence
  • Market Indicators
    • Table 1 Life Expectancy at Birth 2001-2006
  • Market Data
    • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
    • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
    • Table 4 OTC Healthcare Company Shares by Retail Value 2002-20068
    • Table 5 OTC Healthcare Brand Shares by Retail Value 2003-20069
    • Table 6 Penetration of Private Label by Sector 2002-2006
    • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
    • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
    • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
    • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
  • Appendix
    • OTC Registration and Classification
    • Vitamins and Dietary Supplements Registration and Classification17
    • Generics
    • Consumer Expenditure on Health Goods and Medical Services19
    • Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
  • Definitions
    • Local Company Profiles - Japan
  • Eisai Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 1 Eisai Co Ltd: Key Facts21
    • Summary 2 Eisai Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning22
    • Summary 3 Eisai Co Ltd: Competitive Position 2006
  • Hisamitsu Pharmaceutical Co Inc
    • Strategic Direction
    • Key Facts
    • Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
    • Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2006
  • Lion Corp
    • Strategic Direction
    • Key Facts
    • Summary 7 Lion Corp: Key Facts
    • Summary 8 Lion Corp: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 9 Lion Corp: Competitive Position 2006
  • Miki Corp
    • Strategic Direction
    • Key Facts
    • Summary 10 Miki Corp: Key Facts
    • Summary 11 Miki Corp: Operational Indicators27
    • Company Background
    • Production
    • Summary 12 Miki Corp: Production Statistics 2006
    • Competitive Positioning
    • Summary 13 Miki Corp: Competitive Position 2006
  • Rohto Pharmaceutical Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 14 Rohto Pharmaceutical Co Ltd: Key Facts
    • Summary 15 Rohto Pharmaceutical Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Summary 16 Rohto Pharmaceutical Co Ltd: Production Statistics 2006
    • Competitive Positioning
    • Summary 17 Rohto Pharmaceutical Co Ltd: Competitive Position 2006
  • Sankyo Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 18 Sankyo Co Ltd: Key Facts31
    • Summary 19 Sankyo Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 20 Sankyo Co Ltd: Competitive Position 2006
  • Sato Pharmaceutical Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 21 Sato Pharmaceutical Co Ltd: Key Facts
    • Company Background
    • Production
    • Summary 22 Sato Pharmaceutical Co Ltd: Production Statistics 2006
    • Competitive Positioning35
    • Summary 23 Sato Pharmaceutical Co Ltd: Competitive Position 2006
  • Ssp Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 24 SSP Co Ltd: Key Facts
    • Summary 25 SSP Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 26 SSP Co Ltd: Competitive Position 2006
  • Taisho Pharmaceutical Co Ltd
    • Strategic Direction
    • Key Facts
    • Summary 27 Taisho Pharmaceutical Co Ltd: Key Facts
    • Summary 28 Taisho Pharmaceutical Co Ltd]: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 29 Taisho Pharmaceutical Co Ltd: Competitive Position 2006
  • Takeda Chemical Industries Ltd
    • Strategic Direction
    • Key Facts
    • Summary 30 Takeda Chemical Industries Ltd: Key Facts
    • Summary 31 Takeda Chemical Industries Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
    • Summary 32 Takeda Chemical Industries Ltd: Competitive Position 2006
  • Eye Care In Japan
  • Sector Data
    • Table 12 Sales of Eye Care by Subsector: Value 2001-2006
    • Table 13 Sales of Eye Care by Subsector: % Value Growth 2001-2006
    • Table 14 Eye Care Company Shares by Retail Value 2002-2006
    • Table 15 Eye Care Brand Shares by Retail Value 2003-2006
    • Table 16 Forecast Sales of Eye Care by Subsector: Value 2006-2011
    • Table 17 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011